Human lung hydrolases delineate Mycobacterium tuberculosis-macrophage interactions and the capacity to control infection

Journal of Immunology

Volumn 187, Issue 1, 2011, Pages 372-381

  Arcos, Jesús ^a   Sasindran, Smitha J ^a   Fujiwara, Nagatoshi ^b   Turner, Joanne ^a   Schlesinger, Larry S ^a   Torrelles, Jordi B ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROLASE;

ARTICLE; BACTERIAL CELL; BACTERIAL GROWTH; BACTERIAL STRAIN; CELL INTERACTION; CELL MIGRATION; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFECTION CONTROL; LUNG ALVEOLUS; LUNG LAVAGE; LUNG PARENCHYMA; MACROPHAGE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; CELL WALL; HOST-PATHOGEN INTERACTIONS; HUMANS; HYDROLASES; INFLAMMATION MEDIATORS; LUNG; MACROPHAGES, ALVEOLAR; MICROSCOPY, ELECTRON, TRANSMISSION; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS, PULMONARY;

EID: 79960425152     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1100823     Document Type: Article

References (54)

1. World Health Organization. 2010. Multidrug and Extensively Drug-Resistant TB (M/XDR-TB): 2010 Global Report on Surveillance and Response. WHO Press, Geneva, Switzerland.
2. Schlesinger, L. S. 1997. The role of mononuclear phagocytes in tuberculosis. In Lung macrophages and dendritic cells in health and disease. M. F. Lipscomb, and S. W. Russell, eds. Marcel Dekker, Inc., New York, p. 437-480.
3. Torrelles, J. B., and L. S. Schlesinger. 2010. Diversity in Mycobacterium tuberculosis mannosylated cell wall determinants impacts adaptation to the host. Tuberculosis (Edinb.) 90: 84-93.
4. King, R. J. 1982. Pulmonary surfactant. J. Appl. Physiol. 53: 1-8.
5. van Golde, L. M. 1985. Synthesis of surfactant lipids in the adult lung. Annu. Rev. Physiol. 47: 765-774.
6. Griese, M. 1999. Pulmonary surfactant in health and human lung diseases: state of the art. Eur. Respir. J. 13: 1455-1476.
7. Weaver, T. E., and J. A. Whitsett. 1991. Function and regulation of expression of pulmonary surfactant-associated proteins. Biochem. J. 273: 249-264.
8. Singh, G., S. L. Katyal, W. E. Brown, D. L. Collins, and R. J. Mason. 1988. Pulmonary lysozyme - a secretory protein of type II pneumocytes in the rat. Am. Rev. Respir. Dis. 138: 1261-1267.
9. Haller, E. M., S. A. Shelley, M. R. Montgomery, and J. U. Balis. 1992. Immunocytochemical localization of lysozyme and surfactant protein A in rat type II cells and extracellular surfactant forms. J. Histochem. Cytochem. 40: 1491-1500.
10. Hook, G. E., and L. B. Gilmore. 1982. Hydrolases of pulmonary lysosomes and lamellar bodies. J. Biol. Chem. 257: 9211-9220.
11. Nicod, L. P. 2005. Lung defenses: An overview. Eur. Resp. Rev. 14: 45-50.
12. Hiemstra, P. S., and R. Bals. 2004. Series introduction: Innate host defense of the respiratory epithelium. J. Leukoc. Biol. 75: 3-4.
13. Williams, M. C. 2003. Alveolar type I cells: molecular phenotype and development. Annu. Rev. Physiol. 65: 669-695.
14. Mason, R. J. 2006. Biology of alveolar type II cells. Respirology 11(Suppl): S12-S15.
15. Schlesinger, L. S., A. K. Azad, J. B. Torrelles, E. Roberts, I. Vergne, and V. Deretic. 2008. Determinants of phagocytosis, phagosome biogenesis and autophagy for Mycobacterium tuberculosis. In Handbook of Tuberculosis. Immunology and Cell Biology. S. H. E. Kaufmann, and W. J. Britton, eds. Wiley- VCH Verlag, Weinheim, Germany, pp. 1-22.
16. Ryll, R., Y. Kumazawa, and I. Yano. 2001. Immunological properties of trehalose dimycolate (cord factor) and other mycolic acid-containing glycolipids - a review. Microbiol. Immunol. 45: 801-811.
17. Hunter, R. L., M. R. Olsen, C. Jagannath, and J. K. Actor. 2006. Multiple roles of cord factor in the pathogenesis of primary, secondary, and cavitary tuberculosis, including a revised description of the pathology of secondary disease. Ann. Clin. Lab. Sci. 36: 371-386.
18. Kang, P. B., A. K. Azad, J. B. Torrelles, T. M. Kaufman, A. Beharka, E. Tibesar, L. E. DesJardin, and L. S. Schlesinger. 2005. The human macrophage mannose receptor directs Mycobacterium tuberculosis lipoarabinomannan-mediated phagosome biogenesis. J. Exp. Med. 202: 987-999.
19. Fujiwara, N., J. Pan, K. Enomoto, Y. Terano, T. Honda, and I. Yano. 1999. Production and partial characterization of anti-cord factor (trehalose-6,6′-dimycolate) IgG antibody in rabbits recognizing mycolic acid subclasses of Mycobacterium tuberculosis or Mycobacterium avium. FEMS Immunol. Med. Microbiol. 24: 141-149.
20. Torrelles, J. B., R. Knaup, A. Kolareth, T. Slepushkina, T. M. Kaufman, P. B. Kang, P. J. Hill, P. J. Brennan, D. Chatterjee, J. T. Belisle, et al. 2008. Identification of Mycobacterium tuberculosis clinical isolates with altered phagocytosis by human macrophages due to a truncated lipoarabinomannan. J. Biol. Chem. 283: 31417-31428.
21. Ames, B. N. 1966. Assay of inorganic phosphate, total phosphate and phosphatases. Methods Enzymol. 8: 115-118.
22. Hook, G. E. 1978. Extracellular hydrolases of the lung. Biochemistry 17: 520-528.
23. Torrelles, J. B., K. H. Khoo, P. A. Sieling, R. L. Modlin, N. Zhang, A. M. Marques, A. Treumann, C. D. Rithner, P. J. Brennan, and D. Chatterjee. 2004. Truncated structural variants of lipoarabinomannan in Mycobacterium leprae and an ethambutol-resistant strain of Mycobacterium tuberculosis. J. Biol. Chem. 279: 41227-41239.
24. Kaur, D., T. L. Lowary, V. D. Vissa, D. C. Crick, and P. J. Brennan. 2002. Characterization of the epitope of anti-lipoarabinomannan antibodies as the terminal hexaarabinofuranosyl motif of mycobacterial arabinans. Microbiology 148: 3049-3057.
25. Chatterjee, D., K. Lowell, B. Rivoire, M. R. McNeil, and P. J. Brennan. 1992. Lipoarabinomannan of Mycobacterium tuberculosis. Capping with mannosyl residues in some strains. J. Biol. Chem. 267: 6234-6239.
26. Schlesinger, L. S. 1993. Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors. J. Immunol. 150: 2920-2930. (Pubitemid 23127541)
27. Olakanmi, O., B. E. Britigan, and L. S. Schlesinger. 2000. Gallium disrupts iron metabolism of mycobacteria residing within human macrophages. Infect. Immun. 68: 5619-5627.
28. Notter, R. H. 2000. Lung Surfactants: Basic Science and Clinical Applications. Marcel Dekker, New York, p. 1-444.
29. Cohn, Z. A., and E. Wiener. 1963. The particulate hydrolases of macrophages. I. Comparative enzymology, isolation, and properties. J. Exp. Med. 118: 991-1008.
30. Sorber, W. A., E. S. Leake, and Q. N. Myrvik. 1973. Comparative densities of hydrolase-containing granules from normal and BCG-induced alveolar macrophages. Infect. Immun. 7: 86-92.
31. Van Furth, R. 1988. Phagocytic cells: Development and distribution of mononuclear phagocytes in normal steady state and inflammation. In Inflammation: Basic Principles and Clinical Correlates. J. I. Gallin, I. M. Goldstein, and R. Snyderman, eds. Raven, New York, p. 281-295.
32. Dong, X., S. Bhamidi, M. Scherman, Y. Xin, and M. R. McNeil. 2006. Development of a quantitative assay for mycobacterial endogenous arabinase and ensuing studies of arabinase levels and arabinan metabolism in Mycobacterium smegmatis. Appl. Environ. Microbiol. 72: 2601-2605.
33. Flynn, J. L., and J. Chan. 2001. Immunology of tuberculosis. Annu. Rev. Immunol. 19: 93-129.
34. Fenton, M. J., L. W. Riley, and L. S. Schlesinger. 2005. Receptor-mediated recognition of Mycobacterium tuberculosis by host cells. In Tuberculosis and the Tubercle Bacillus. S. T. Cole, K. D. Eisenach, D. N. McMurray, and W. R. Jacobs Jr., eds. ASM Press, New York, p. 405-426.
35. Fehrenbach, H. 2001. Alveolar epithelial type II cell: defender of the alveolus revisited. Respir. Res. 2: 33-46.
36. DiAugustine, R. P. 1974. Lung concentric laminar organelle. Hydrolase activity and compositional analysis. J. Biol. Chem. 249: 584-593.
37. Gilder, H., R. H. Haschemeyer, G. F. Fairclough, Jr., and D. C. Mynarcik. 1981. Isolation and characterization of lamellar body material from rat lung homogenates by continuous linear sucrose gradients. J. Lipid Res. 22: 1277-1285.
38. Edelson, J. D., J. M. Shannon, and R. J. Mason. 1988. Alkaline phosphatase: a marker of alveolar type II cell differentiation. Am. Rev. Respir. Dis. 138: 1268-1275.
39. de Vries, A. C., A. W. Schram, J. M. Tager, J. J. Batenburg, and L. M. van Golde. 1985. A specific acid alpha-glucosidase in lamellar bodies of the human lung. Biochim. Biophys. Acta 837: 230-238.
40. Young, S. L., E. K. Fram, E. Larson, and J. R. Wright. 1993. Recycling of surfactant lipid and apoprotein-A studied by electron microscopic autoradiography. Am. J. Physiol. 265: L19-L26.
41. Stone, K. C., R. R. Mercer, P. Gehr, B. Stockstill, and J. D. Crapo. 1992. Allometric relationships of cell numbers and size in the mammalian lung. Am. J. Respir. Cell Mol. Biol. 6: 235-243.
42. Stone, K. C., R. R. Mercer, B. A. Freeman, L. Y. Chang, and J. D. Crapo. 1992. Distribution of lung cell numbers and volumes between alveolar and nonalveolar tissue. Am. Rev. Respir. Dis. 146: 454-456.
43. Chroneos, Z. C., K. Midde, Z. Sever-Chroneos, and C. Jagannath. 2009. Pulmonary surfactant and tuberculosis. Tuberculosis (Edinb.) 89(Suppl 1): S10-S14.
44. Patton, J. S. 1996. Mechanisms of macromolecule absorption by the lungs. Adv. Drug Deliv. Rev. 19: 3-36.
45. Dannenberg, A. M., Jr., M. S. Burstone, P. C. Walter, and J. W. Kinsley. 1963. A histochemical study of phagocytic and enzymatic functions of rabbit mononuclear and polymorphonuclear exudate cells and alveolar macrophages. I. Survey and quantitation of enzymes, and states of cellular activation. J. Cell Biol. 17: 465-486.
46. Ehle, H., E. Müller, and A. Horn. 1985. Alkaline phosphatase of the calf intestine hydrolyzes phospholipids. FEBS Lett. 183: 413-416. (Pubitemid 15042762)
47. Findlay, G. H. 1955. The simple esterases of human skin. Br. J. Dermatol. 67: 83-91.
48. Wells, G. C. 1957. Esterases in cutaneous granulomata. Br. J. Dermatol. 69: 415-427.
49. Steigleder, G. K., and K. Schultis. 1957. Histochemistry of skin esterases. Arch. Klin. Exp. Dermatol. 205: 196-211.
50. Annenkov, G. A., N. N. Klepikov, L. P. Martynova, and V. A. Puzanov. 2004. Wide range of the use of natural lipases and esterases to inhibit Mycobacterium tuberculosis. Probl. Tuberk. Bolezn. Legk. 6: 52-56.
51. Torrelles, J. B., A. K. Azad, and L. S. Schlesinger. 2006. Fine discrimination in the recognition of individual species of phosphatidyl-myo- inositol mannosides from Mycobacterium tuberculosis by C-type lectin pattern recognition receptors. J. Immunol. 177: 1805-1816.
52. Astarie-Dequeker, C., E. N. N'Diaye, V. Le Cabec, M. G. Rittig, J. Prandi, and I. Maridonneau-Parini. 1999. The mannose receptor mediates uptake of pathogenic and nonpathogenic mycobacteria and bypasses bactericidal responses in human macrophages. Infect. Immun. 67: 469-477.
53. Nigou, J., C. Zelle-Rieser, M. Gilleron, M. Thurnher, and G. Puzo. 2001. Mannosylated lipoarabinomannans inhibit IL-12 production by human dendritic cells: evidence for a negative signal delivered through the mannose receptor. J. Immunol. 166: 7477-7485. (Pubitemid 32525626)
54. Chieppa, M., G. Bianchi, A. Doni, A. Del Prete, M. Sironi, G. Laskarin, P. Monti, L. Piemonti, A. Biondi, A. Mantovani, et al. 2003. Cross-linking of the mannose receptor on monocyte-derived dendritic cells activates an anti-inflammatory immunosuppressive program. J. Immunol. 171: 4552-4560. (Pubitemid 37310570)